[LXRX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
12-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -106.65%
YoY- 89.25%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 23 234 27 199 6,634 9,163 7,999 -97.97%
PBT -23,122 -18,067 -20,958 -5,495 82,603 -69,071 -66,611 -50.57%
Tax -90 19 48 -174 4,118 5,125 958 -
NP -23,122 -18,067 -20,958 -5,495 82,603 -69,071 -66,611 -50.57%
Tax Rate - - - - -4.99% - - -
Total Cost 23,145 18,301 20,985 5,694 -75,969 78,234 74,610 -54.14%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -100,530.43 -7,720.94 -77,622.22 -2,761.31 1,245.15 -753.80 -832.74 2335.52%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.16 -0.13 -0.15 -0.04 0.77 -0.65 -0.63 -59.86%
EPS Diluted -0.16 -0.13 -0.15 -0.04 0.71 -0.65 -0.63 -59.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.